jueves, 3 de septiembre de 2026

Abivax has still not been acquired. What’s going on? The French drugmaker has been the subject of frenzied rumors, but it remains unbetrothed By Adam FeuersteinSept. 3, 2026 Senior Writer, Biotech

https://www.statnews.com/2026/09/03/abivax-acquisition-target-replimune-fda/

No hay comentarios: